Melanocyte-Directed enzyme prodrug therapy (MDEPT): Development of second generation prodrugs for targeted treatment of malignant melanoma
- 30 June 2001
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 9 (6) , 1549-1558
- https://doi.org/10.1016/s0968-0896(01)00039-6
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Melanocyte-directed enzyme prodrug therapy (MDEPT): development of a targeted treatment for malignant melanomaBioorganic & Medicinal Chemistry, 1999
- Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.Journal of Clinical Oncology, 1998
- The stereoselective synthesis of cyclomaltopentaose. A novel cyclodextrin homologue with D.P. fiveTetrahedron Letters, 1994
- Mechanistic studies on dopamine .beta.-monooxygenase catalysis: N-dealkylation and mechanism-based inhibition by benzylic-nitrogen-containing compounds. Evidence for a single-electron-transfer mechanismJournal of the American Chemical Society, 1987
- Antihypertensive activities of phenyl aminoethyl sulfides, a class of synthetic substrates for dopamine .beta.-hydroxylaseJournal of Medicinal Chemistry, 1984
- The transformation using the soft NO⊕-speciesTetrahedron, 1982
- Host-guest complexation. 11. Survey of chiral recognition of amine and amino ester salts by dilocular bisdinaphthyl hostsJournal of the American Chemical Society, 1978
- Aryl-2-halogenoalkylamines—XXIV. Derivatives of o-, m- and p-aminophenol: Synthesis and antineoplastic activitiesBiochemical Pharmacology, 1968
- 460. Cytotoxic compounds. Part II. Some amides of the “nitrogen mustard” typeJournal of the Chemical Society, 1961